Dendritic cell vaccination with partial Treg depletion in relapsed glioblastoma - results from the pilot phase of the HIT-HGG Rez Immunvac study

ISSN
2326-6074
2326-6066
Date Issued
2016
Author(s)
Eyrich, Matthias
Krauss, Juergen
Loehr, Mario
Technau, Antje
Rachor, Johannes
Monoranu, Camelia
Warmuth-Metz, Monika
Woelfl, Matthias
Schlegel, Paul Gerhardt
DOI
10.1158/2326-6074.CRICIMTEATIAACR15-A045